BEKHealth
Venture Round in 2025
BEKhealth is a clinical research software company that utilizes an AI-powered platform to enhance the efficiency of clinical trials and observational studies. By automating various processes, BEKhealth enables organizations to better understand their patient populations, optimize feasibility, and speed up site selection. The platform extracts and processes both structured and unstructured data from electronic medical records, allowing for a more comprehensive understanding of trial eligibility criteria. This capability leads to the identification of significantly more protocol-eligible candidates, resulting in a tenfold increase in qualified patients and halving the enrollment timeline. Through its innovative approach, BEKhealth aims to reduce costs and streamline the overall clinical research process for its clients.
Korio is a company that specializes in developing a compliance-centric platform focused on randomization and trial supply management for the clinical research industry. The platform integrates advanced IRT design intelligence to tackle operational inefficiencies, cumbersome manual processes, and subpar user experiences. With a role-based interface, Korio's solution offers functionalities for randomization, trial supply management, and data management, facilitating efficient workflows. Additionally, the platform provides users with direct access to the leadership team, enhancing communication and ensuring that users can operate with confidence. Korio's emphasis on industry compliance positions it as a valuable resource for organizations navigating the complexities of clinical trials.
S2N Health
Seed Round in 2024
S2N Health is a strategic consulting firm that specializes in providing business and marketing strategy support to the medical technology sector. Established in 2011, the company has partnered with over 160 organizations, from startups to large global firms, delivering insights and analytics that inform critical product, commercial, and business decisions. S2N Health offers a comprehensive range of services throughout various phases of development, including market entry, sales acceleration, and strategic partnerships. In 2022, the firm launched RepSignal, an AI-driven SaaS solution designed to furnish medtech commercial teams with real-time customer insights and intelligence, enhancing their ability to effectively target and engage clinical customers. By leveraging a network of experts across regulatory, reimbursement, and other disciplines, S2N Health aims to empower healthcare companies to achieve growth and success in a competitive landscape.
KAID Health
Venture Round in 2023
KAID Health specializes in artificial intelligence and natural language processing tailored for healthcare organizations. The company has developed an AI-enabled clinical analysis and provider engagement platform designed to automate various aspects of care management by utilizing comprehensive patient data. This platform identifies gaps in patient care and seamlessly integrates these insights into providers' workflows, facilitating timely interventions. KAID Health's solution is applicable across diverse clinical settings and automates quality metric reporting for primary care providers. By enhancing provider-patient engagement, the company empowers care teams to better assist patients while allowing clinicians to focus on delivering empathetic and informed care.
Korio
Venture Round in 2023
Korio is a company that specializes in developing a compliance-centric platform focused on randomization and trial supply management for the clinical research industry. The platform integrates advanced IRT design intelligence to tackle operational inefficiencies, cumbersome manual processes, and subpar user experiences. With a role-based interface, Korio's solution offers functionalities for randomization, trial supply management, and data management, facilitating efficient workflows. Additionally, the platform provides users with direct access to the leadership team, enhancing communication and ensuring that users can operate with confidence. Korio's emphasis on industry compliance positions it as a valuable resource for organizations navigating the complexities of clinical trials.
QuantHealth
Series A in 2023
QuantHealth is a company focused on enhancing drug development through artificial intelligence-based software. This software is designed to conduct patient-centric simulations that accelerate and de-risk the drug development process. By integrating diverse data points from the clinical and drug development landscape, QuantHealth predicts patient responses to both existing and new therapies. This capability allows pharmaceutical and biotechnology firms to explore various scenarios within their clinical trials, optimizing trial designs and improving the likelihood of successful outcomes. Ultimately, QuantHealth's solutions facilitate the discovery of new clinical opportunities and strategies for optimizing drug development.
Atropos Health
Series A in 2022
Atropos Health, founded in 2019 and based in Palo Alto, California, specializes in developing a digital prognostogram platform that transforms health data into usable real-world evidence. The Atropos Evidence Platform integrates electronic medical record (EMR) data to generate digital evidence tailored to individual patient outcomes. It serves a diverse clientele, including healthcare organizations, life science companies, and researchers, by enabling them to derive value from previously isolated EMR data. This cloud-based platform addresses evidence gaps from bench to bedside, enhances clinical outcomes through data-driven care, and accelerates research efforts in the medical field.
CubeWorks
Seed Round in 2022
CubeWorks Inc. is a technology company based in Ann Arbor, Michigan, founded in 2013. It specializes in millimeter-scale computing solutions, focusing on the development of ultra-small wireless smart sensors. The company's flagship product, the Cubisens platform, is an autonomous wireless sensing system capable of measuring various parameters, including imaging, temperature, and pressure, with precision of less than a millimeter. These sensors are lightweight, durable, and designed for diverse applications such as healthcare logistics, supply chain management, cold chain monitoring, security, and environmental monitoring. By enabling the integration of multiple units, CubeWorks' solutions provide critical real-time data and analytics, facilitating enhanced visibility in complex monitoring and sensing tasks, thereby advancing the Internet of Things landscape.
KAID Health
Series A in 2022
KAID Health specializes in artificial intelligence and natural language processing tailored for healthcare organizations. The company has developed an AI-enabled clinical analysis and provider engagement platform designed to automate various aspects of care management by utilizing comprehensive patient data. This platform identifies gaps in patient care and seamlessly integrates these insights into providers' workflows, facilitating timely interventions. KAID Health's solution is applicable across diverse clinical settings and automates quality metric reporting for primary care providers. By enhancing provider-patient engagement, the company empowers care teams to better assist patients while allowing clinicians to focus on delivering empathetic and informed care.
Huma.AI, Inc. is a technology company based in Palo Alto, California, founded in 2016. It specializes in developing a knowledge automation platform aimed at improving efficiency within the healthcare and pharmaceutical industries. The platform addresses the challenges posed by complex and disparate data systems by connecting various data silos through natural human language. By extracting insights from unstructured data, such as documents and free text, Huma.AI enables users—including companies, scientists, and clinicians—to easily access information and make informed decisions quickly. This innovative approach not only streamlines data access but also allows users to interact with data using everyday language, thereby enhancing the decision-making process in healthcare.
Reveleer
Venture Round in 2021
Reveleer is a healthcare software and services company that operates a Software-as-a-Service analytics platform focused on medical record analysis and targeted solutions. Founded in 2009 and based in Glendale, California, the company enables payers across Medicare, Medicaid, and commercial sectors to effectively manage risk adjustment and quality improvement programs. Reveleer's platform provides a comprehensive suite of services, including medical record collection, retrieval, coding, and abstraction, all integrated into a single system. Additionally, the company offers professional services such as abstractor training, auditing, and strategic assessments to enhance operational practices and data management. Formerly known as Health Data Vision, Inc., Reveleer rebranded in August 2019 to reflect its commitment to empowering healthcare organizations to take control of their data and improve coding accuracy.
CareAlign
Seed Round in 2021
CareAlign is a developer of a real-time data system that enhances the management and coordination of clinical care for clinicians. The company offers an intuitive, patient-centric task management tool that allows healthcare professionals to assign tasks, set deadlines, and categorize them based on urgency. By aggregating data from multiple sources, CareAlign provides a comprehensive and clinically intuitive display of patients' clinical status, facilitating better understanding and decision-making in patient care. This system aims to streamline workflows and improve communication among clinicians, ultimately enhancing the quality of care delivered to patients.
BEKHealth
Seed Round in 2021
BEKhealth is a clinical research software company that utilizes an AI-powered platform to enhance the efficiency of clinical trials and observational studies. By automating various processes, BEKhealth enables organizations to better understand their patient populations, optimize feasibility, and speed up site selection. The platform extracts and processes both structured and unstructured data from electronic medical records, allowing for a more comprehensive understanding of trial eligibility criteria. This capability leads to the identification of significantly more protocol-eligible candidates, resulting in a tenfold increase in qualified patients and halving the enrollment timeline. Through its innovative approach, BEKhealth aims to reduce costs and streamline the overall clinical research process for its clients.
Clinical Research IO
Series A in 2021
Clinical Research IO is a health technology company based in Boston, Massachusetts, specializing in e-source and site operation software for clinical research sites. The company's platform allows users to build and customize clinical source templates from a comprehensive library, facilitating the identification and correction of source data errors. Additionally, it manages patient compliance through scheduling features and automated text reminders, enhancing both patient recruitment and retention with dedicated modules. By providing a unified system for regulatory workflows, Clinical Research IO supports pharmaceutical companies, biotech firms, research sites, and academic institutions in streamlining their clinical research processes.
Turbine
Seed Round in 2021
Turbine Ltd, established in 2015 and headquartered in Budapest, Hungary, specializes in computational biology for cancer drug development. The company's core product is a predictive model that simulates cellular behavior, aiding in the discovery, preclinical testing, and development of cancer therapies. Turbine's platform leverages proprietary Simulated Cell technology and artificial intelligence to identify novel protein targets and precision biomarkers, ultimately enhancing the translation of research into effective patient treatments.
SomaLogic
Series A in 2020
SomaLogic, Inc. is a commercial-stage company based in Boulder, Colorado, specializing in protein biomarker discovery and clinical diagnostics. Founded in 1999, the company has developed advanced technologies such as SOMAmers, slow off-rate modified aptamers that specifically bind to target proteins, and the SOMAscan platform, which facilitates comprehensive protein measurement. This innovative approach allows for the analysis of protein biomarker signatures, significantly enhancing the understanding of health and disease beyond traditional genomic methods. SomaLogic's products are utilized in a variety of applications, including diagnostics for conditions in oncology, neurology, and cardiovascular and metabolic diseases, as well as in drug discovery and development. The company also offers diagnostic tests and protein measurement solutions for life science and biopharma researchers, contributing to advancements in medical science.
COTA Healthcare
Series D in 2020
COTA, Inc. is a Boston-based company that specializes in developing a platform designed to provide data and insights related to cancer patients, aimed at guiding treatment decisions. Founded in 2011 by a team of doctors, engineers, and data scientists, COTA utilizes proprietary technology and advanced analytics to transform fragmented electronic health record (EHR) data into cohesive, research-grade information. This platform supports oncology practices and cancer centers by identifying variations in care, thus enabling the design of effective treatment programs and payment models. COTA's solutions serve a diverse range of stakeholders, including healthcare providers, payers, life sciences companies, and the FDA, ultimately striving to enhance patient outcomes and reduce healthcare costs associated with cancer care.
Cecelia Health
Series B in 2020
Cecelia Health, Inc. is a technology-enabled company based in New York that specializes in remote telehealth support and chronic disease management, particularly focusing on diabetes care. Founded in 2006 and formerly known as Fit4D, the company provides clinical support and coaching services for individuals with Type 1 and Type 2 diabetes, as well as those managing other chronic conditions such as obesity and cardiovascular disease. Cecelia Health combines expert clinical coaching with digital health tools to enhance patient adherence to medications and wellness programs. The company's approach emphasizes personalized coaching and patient engagement, utilizing both virtual care and telehealth solutions to improve health outcomes. Through its services, Cecelia Health aims to transform the lives of its patients by fostering better self-management and promoting positive behavior changes.
CareAlign
Seed Round in 2020
CareAlign is a developer of a real-time data system that enhances the management and coordination of clinical care for clinicians. The company offers an intuitive, patient-centric task management tool that allows healthcare professionals to assign tasks, set deadlines, and categorize them based on urgency. By aggregating data from multiple sources, CareAlign provides a comprehensive and clinically intuitive display of patients' clinical status, facilitating better understanding and decision-making in patient care. This system aims to streamline workflows and improve communication among clinicians, ultimately enhancing the quality of care delivered to patients.
Digital Cognitive Technologies
Venture Round in 2020
Digital Cognition Technologies, Inc. specializes in the research and development of non-invasive tests designed to detect presymptomatic cognitive impairment. The company’s innovative approach involves analyzing micro-movements in drawing behavior, which provide insights into an individual's memory and thinking processes. These tests are utilized in various contexts, including drug development, where they facilitate the pre-screening of participants and help assess the efficacy of treatments by identifying subtle cognitive changes. Additionally, the tests support researchers in early detection and intervention strategies, enabling timely treatment with both investigational therapies and established medications. Founded in 2015 and based in Waltham, Massachusetts, Digital Cognition Technologies aims to enhance patient care and improve treatment outcomes through early identification of cognitive decline.
iQuartic
Venture Round in 2020
iQuartic, Inc. is a healthcare technology company that develops cloud-based platforms for electronic health record (EHR) networking and data mining. Founded in 2012 and headquartered in Boston, Massachusetts, iQuartic's technology supports various functions in the healthcare sector, including EHR and claims auditing, quality benchmarking, population health management, disease management, and risk profiling. Its flagship product, the iQ EHR Network, integrates disparate EHR systems from multiple facilities and processes real-time data analytics. Additionally, iQuartic offers a suite of products designed for specific applications, such as the EHR Data Auditor for analyzing patient group behaviors, the Diabetes Management Scorecard for assessing diabetes management, and the Readmission Predictor for identifying patients at risk of hospital readmission. Other tools include the Predictive Claims Auditor for detecting clinical data errors and the Clinician Profiler for evaluating clinician performance and practice variations. Overall, iQuartic aims to enhance healthcare outcomes through advanced analytics and integrated data solutions.
Health Decisions
Venture Round in 2020
Health Decisions, Inc. is a clinical research organization (CRO) based in Durham, North Carolina, that specializes in providing comprehensive clinical research services. Founded in 1989, the company has a strong focus on women’s health, having conducted over 100 clinical trials in areas such as contraception and postmenopausal vasomotor symptoms. In addition to its work in women’s health, Health Decisions has expanded into diagnostics, successfully conducting studies for high-risk HPV types, preterm birth risk, and various oncology indications. The company offers a range of services including project management, medical writing, data management, biostatistics, quality management, and regulatory compliance. Health Decisions aims to facilitate the rapid and efficient development of women's health products and diagnostics, providing tailored solutions that align with the specific needs of its partners.
Reveleer is a healthcare software and services company that operates a Software-as-a-Service analytics platform focused on medical record analysis and targeted solutions. Founded in 2009 and based in Glendale, California, the company enables payers across Medicare, Medicaid, and commercial sectors to effectively manage risk adjustment and quality improvement programs. Reveleer's platform provides a comprehensive suite of services, including medical record collection, retrieval, coding, and abstraction, all integrated into a single system. Additionally, the company offers professional services such as abstractor training, auditing, and strategic assessments to enhance operational practices and data management. Formerly known as Health Data Vision, Inc., Reveleer rebranded in August 2019 to reflect its commitment to empowering healthcare organizations to take control of their data and improve coding accuracy.
Forefront TeleCare
Series A in 2019
Forefront TeleCare, Inc. is a leading provider of behavioral telehealth services in the United States, specializing in telepsychiatry, telepsychology, and telepsychotherapy. Founded in 2005 and based in Novato, California, the company offers a HIPAA-compliant Telehealth platform that includes in-facility equipment, training, and logistical support to healthcare providers and facilities, particularly targeting small and rural healthcare settings. Forefront TeleCare ensures secure, high-quality audio and video connections between mental health professionals and patients, enhancing access to psychiatric care. The organization collaborates with skilled nursing facilities and clinics across 18 states, leveraging a network of psychiatrists, clinical psychologists, and psychiatric nurse practitioners to deliver essential mental health services. With a commitment to improving the quality of life for seniors and other patients in need, Forefront TeleCare is a pioneer in integrating virtual behavioral health care into traditional healthcare frameworks.
Roobrik
Venture Round in 2018
Roobrik, Inc. is a company that specializes in providing online assessment and decision-making tools aimed at assisting older adults and their caregivers in navigating health and care choices. Founded in 2013 and headquartered in Greensboro, North Carolina, Roobrik focuses on promoting informed decision-making by offering resources that address critical aspects of later-life care, including driving safety, home safety, and managing conditions like dementia. By simplifying the decision-making process, Roobrik enables families to enhance health and wellness outcomes while potentially reducing costs associated with long-term care.
COTA Healthcare
Series C in 2018
COTA, Inc. is a Boston-based company that specializes in developing a platform designed to provide data and insights related to cancer patients, aimed at guiding treatment decisions. Founded in 2011 by a team of doctors, engineers, and data scientists, COTA utilizes proprietary technology and advanced analytics to transform fragmented electronic health record (EHR) data into cohesive, research-grade information. This platform supports oncology practices and cancer centers by identifying variations in care, thus enabling the design of effective treatment programs and payment models. COTA's solutions serve a diverse range of stakeholders, including healthcare providers, payers, life sciences companies, and the FDA, ultimately striving to enhance patient outcomes and reduce healthcare costs associated with cancer care.
Mingle Health
Venture Round in 2018
Mingle Health is a healthcare informatics company established in 2011 and based in Sandy, Utah. The company has developed an end-to-end quality-improvement platform designed to enhance data collection, reporting, and preventive care within the healthcare system. Mingle Health's platform focuses on making healthcare affordable and ensuring that practices remain profitable. It offers streamlined reporting and consulting services tailored to healthcare organizations of all sizes, assisting them in optimizing practice management and designing quality improvement programs that align with regulatory requirements. Through its solutions, Mingle Health aims to improve care delivery, reduce costs, and transform healthcare operations, ultimately enhancing both the joy and profitability of medical practices.
C2Sense
Seed Round in 2017
C2Sense, Inc., founded in 2013 and based in Cambridge, Massachusetts, specializes in developing chemiresistive gas sensors for applications in food and agriculture. Their sensors are designed to detect gases such as ethylene and biogenic amines at low concentrations, monitoring fruit ripeness and the freshness of meat, fish, and poultry throughout the supply chain. This technology helps improve food quality and reduce waste by enabling informed decisions at every stage from growers to consumers. Additionally, C2Sense is working on Halo Diagnostics, a digitally connected immunoassay reader that provides near-PCR sensitivity for patient-to-provider workflows. The company also offers sensing solutions for product quality information and counterfeit detection, using molecular additives that can be integrated into products or packaging to provide real-time status updates and detect issues during distribution.
Bivarus, Inc. is a Durham, North Carolina-based company that specializes in developing a cloud-based analytics platform aimed at enhancing the patient experience in healthcare settings. Founded in 2010, Bivarus emerged from academic research that established patient experience as a key factor in determining health outcomes. The platform provides healthcare leaders with real-time, actionable insights into factors affecting patient experience, provider performance, and overall service operations. By utilizing a sophisticated sampling algorithm, Bivarus delivers targeted measures to patients, enabling organizations to identify root causes of service issues and track quality improvement initiatives effectively. Additionally, Bivarus is recognized as a CMS-approved CAHPS® partner, offering comprehensive services that include measuring employee perceptions of organizational effectiveness and engagement. As a subsidiary of Press Ganey Holdings, Inc., Bivarus continues to play a pivotal role in transforming how healthcare organizations understand and enhance the patient experience.
COTA Healthcare
Series B in 2016
COTA, Inc. is a Boston-based company that specializes in developing a platform designed to provide data and insights related to cancer patients, aimed at guiding treatment decisions. Founded in 2011 by a team of doctors, engineers, and data scientists, COTA utilizes proprietary technology and advanced analytics to transform fragmented electronic health record (EHR) data into cohesive, research-grade information. This platform supports oncology practices and cancer centers by identifying variations in care, thus enabling the design of effective treatment programs and payment models. COTA's solutions serve a diverse range of stakeholders, including healthcare providers, payers, life sciences companies, and the FDA, ultimately striving to enhance patient outcomes and reduce healthcare costs associated with cancer care.
BC Platforms
Venture Round in 2016
BC Platforms is a technology company that specializes in providing a unique data and technology platform for life sciences and healthcare companies. Their Data Access Platform offers access to valuable real-world data (RWD), clinical, genomics, and omics data through a data-as-a-service model. This enables pharmaceutical companies to enhance various use cases within the research and development continuum, from early discovery to post-market processes. The company's technology platform also supports healthcare providers and life science companies in producing, managing, and analyzing complex genomic data as a clinical decision-support solution. BC Platforms' Data Partner Network covers over 22 million life-years of highly curated patient data from around the world, ensuring compatibility with relevant technical standards and compliance with local privacy laws.
Bivarus, Inc. is a Durham, North Carolina-based company that specializes in developing a cloud-based analytics platform aimed at enhancing the patient experience in healthcare settings. Founded in 2010, Bivarus emerged from academic research that established patient experience as a key factor in determining health outcomes. The platform provides healthcare leaders with real-time, actionable insights into factors affecting patient experience, provider performance, and overall service operations. By utilizing a sophisticated sampling algorithm, Bivarus delivers targeted measures to patients, enabling organizations to identify root causes of service issues and track quality improvement initiatives effectively. Additionally, Bivarus is recognized as a CMS-approved CAHPS® partner, offering comprehensive services that include measuring employee perceptions of organizational effectiveness and engagement. As a subsidiary of Press Ganey Holdings, Inc., Bivarus continues to play a pivotal role in transforming how healthcare organizations understand and enhance the patient experience.
Collegium Pharmaceutical
Venture Round in 2015
Collegium Pharmaceutical, Inc. is a specialty pharmaceutical company dedicated to developing and commercializing products aimed at addressing the challenges associated with pain management and the abuse of prescription drugs. The company utilizes its proprietary DETERx platform technology to create abuse-deterrent formulations that maintain the extended-release and safety profiles of medications, making them less susceptible to misuse through methods such as chewing or injecting. Collegium's primary products include Xtampza ER, an abuse-deterrent extended-release formulation of oxycodone, and Nucynta, which encompasses both extended-release and immediate-release formulations of tapentadol for managing severe pain. Founded in 2002 and headquartered in Stoughton, Massachusetts, Collegium focuses on delivering innovative solutions that enhance patient safety while effectively treating chronic pain conditions.
G-Form
Venture Round in 2015
G-Form, LLC is a manufacturer of innovative protective solutions based in Providence, Rhode Island, founded in 2010. The company specializes in creating impact protection equipment for both athletic and consumer electronic applications. Its product range includes lightweight knee pads, elbow guards, compression shorts, and protective gear designed for various sports such as baseball, soccer, hockey, and action sports like mountain biking and snowboarding. G-Form's technology enables its products to harden upon impact, providing superior protection while maintaining comfort and freedom of motion. Additionally, the company offers protective cases for electronic devices, including laptops and tablets. G-Form distributes its products through retailers and distributors in the United States and internationally, as well as through its online platform.
Avhana Health
Seed Round in 2014
Avhana Health Inc., established in 2014 and based in Baltimore, Maryland, specializes in streamlining healthcare provider workflows through its application. This platform integrates with electronic health records (EHR) to deliver real-time, patient-specific clinical recommendations, actionable guidelines, and performance metrics directly within the EHR interface. The software facilitates pre-visit planning, suggests relevant orders that can be submitted directly into the EHR, and tracks provider activity for performance evaluation. Avhana Health's mission is to empower healthcare teams with impactful, patient-specific support to enhance care quality and reduce costs.
Odyssey Logistics & Technology
Venture Round in 2014
Odyssey Logistics & Technology Corporation is a global logistics solutions provider based in Danbury, Connecticut, specializing in managed logistics and transportation services. Founded in 2002, the company operates a freight network valued at over $3 billion and offers a wide range of services, including intermodal transportation, specialized trucking, international freight forwarding, and warehousing. Odyssey's offerings are designed to enhance supply chain performance through a proprietary technology platform and a network of logistics engineers. The company serves various industries, including chemicals, food, energy, and manufacturing, and is noted for its focus on safety, quality, and sustainability. Its Door-To-Done® approach addresses complex logistics needs while ensuring environmentally responsible operations. Additionally, Odyssey is recognized as a Responsible Care® partner by the American Chemistry Council and is involved in community support initiatives. The company's operations extend across North America, Europe, Asia, and the Far East.
Odyssey Logistics & Technology
Venture Round in 2014
Odyssey Logistics & Technology Corporation is a global logistics solutions provider based in Danbury, Connecticut, specializing in managed logistics and transportation services. Founded in 2002, the company operates a freight network valued at over $3 billion and offers a wide range of services, including intermodal transportation, specialized trucking, international freight forwarding, and warehousing. Odyssey's offerings are designed to enhance supply chain performance through a proprietary technology platform and a network of logistics engineers. The company serves various industries, including chemicals, food, energy, and manufacturing, and is noted for its focus on safety, quality, and sustainability. Its Door-To-Done® approach addresses complex logistics needs while ensuring environmentally responsible operations. Additionally, Odyssey is recognized as a Responsible Care® partner by the American Chemistry Council and is involved in community support initiatives. The company's operations extend across North America, Europe, Asia, and the Far East.
PreCision Dermatology
Debt Financing in 2013
PreCision Dermatology is a rapidly growing company dedicated to advancing skincare through innovative therapies. It focuses on developing products that enhance the delivery of active ingredients to the skin, reducing side effects and strengthening the skin's natural barrier. The company's portfolio addresses various dermatological conditions like atopic dermatitis, acne, and rosacea. PreCision Dermatology expands its offerings through internal research, acquisitions, licensing agreements, and strategic partnerships.
Histogenics
Series C in 2012
Histogenics Corporation, founded in 2000 and headquartered in Waltham, Massachusetts, is a regenerative medicine company specializing in the development and commercialization of therapeutic medical products for musculoskeletal conditions. The company's innovative platform integrates cell processing, scaffolding, tissue engineering, bioadhesives, and growth factors to address cartilage damage and improve joint function. Its primary investigational product, NeoCart, is a tissue implant designed to treat cartilage injuries in the knee, aiming to regenerate healthy cartilage and enhance overall joint performance. In 2019, Histogenics was acquired by Ocugen, Inc., marking a significant transition in its corporate structure.
Collegium Pharmaceutical
Venture Round in 2012
Collegium Pharmaceutical, Inc. is a specialty pharmaceutical company dedicated to developing and commercializing products aimed at addressing the challenges associated with pain management and the abuse of prescription drugs. The company utilizes its proprietary DETERx platform technology to create abuse-deterrent formulations that maintain the extended-release and safety profiles of medications, making them less susceptible to misuse through methods such as chewing or injecting. Collegium's primary products include Xtampza ER, an abuse-deterrent extended-release formulation of oxycodone, and Nucynta, which encompasses both extended-release and immediate-release formulations of tapentadol for managing severe pain. Founded in 2002 and headquartered in Stoughton, Massachusetts, Collegium focuses on delivering innovative solutions that enhance patient safety while effectively treating chronic pain conditions.
NuVox Communications
Venture Round in 2012
NuVox Communications is a provider of broadband services that focuses on delivering voice and data network communications to businesses across the United States. The company offers a range of services including conference calling, data security and backup, internet access, voicemail, and web hosting. With a commitment to supporting business communication needs, NuVox aims to enhance operational efficiency and connectivity for its clients through reliable managed services.
Odyssey Logistics & Technology
Venture Round in 2010
Odyssey Logistics & Technology Corporation is a global logistics solutions provider based in Danbury, Connecticut, specializing in managed logistics and transportation services. Founded in 2002, the company operates a freight network valued at over $3 billion and offers a wide range of services, including intermodal transportation, specialized trucking, international freight forwarding, and warehousing. Odyssey's offerings are designed to enhance supply chain performance through a proprietary technology platform and a network of logistics engineers. The company serves various industries, including chemicals, food, energy, and manufacturing, and is noted for its focus on safety, quality, and sustainability. Its Door-To-Done® approach addresses complex logistics needs while ensuring environmentally responsible operations. Additionally, Odyssey is recognized as a Responsible Care® partner by the American Chemistry Council and is involved in community support initiatives. The company's operations extend across North America, Europe, Asia, and the Far East.
SensorLogic
Venture Round in 2010
SensorLogic is a provider of cloud-based, machine-to-machine (M2M) service delivery solutions, specializing in a platform-as-a-service (PaaS) model tailored for M2M applications. The company's offerings include a customizable service delivery platform that features open device and network management, business logic, and complex event processing capabilities. With its XpressIQ Service Suite, SensorLogic enables customers to access ready-to-use applications for GPS tracking, asset monitoring, and control, along with value-added network services. The platform is designed to facilitate the development and deployment of innovative M2M applications, capitalizing on the integration of connected devices within a nationwide GSM/GPRS network.
Nexidia Inc. is a technology company specializing in dialogue and audio analysis products designed to optimize audio and video media. Founded in 2000 and headquartered in Atlanta, Georgia, Nexidia offers a range of solutions including Nexidia Interaction Analytics for analyzing contact center interactions, Nexidia Capture for call recording, and Nexidia Dialogue Search which allows users to search audio content by keywords. The company provides various tools for automating closed captioning and ensuring compliance with video descriptions, as well as Audio Discovery OnDemand for organizing sound recordings. Nexidia also offers consulting, training, support services, and software development kits for unstructured audio search. Its clientele spans multiple industries, including communications, healthcare, financial services, and entertainment, enabling organizations to extract value from unstructured audio and video content. Formerly known as Fast-Talk Communications, Nexidia became a subsidiary of NICE Systems Ltd. in 2016.
CardioMEMS
Venture Round in 2010
CardioMEMS is a medical device company specializing in wireless monitoring solutions for severe chronic cardiovascular conditions. Their proprietary technology involves miniature sensors implanted via minimally invasive procedures, transmitting vital data like cardiac output, blood pressure, and heart rate to enhance patient management, particularly for heart failure, hypertension, and aneurysms.
Coapt Systems
Debt Financing in 2009
Coapt Systems, Inc. specializes in the design, development, and manufacture of bio-absorbable implants used in soft tissue fixation during facial cosmetic surgery. The company offers a range of products, including the ENDOTINE Forehead 3.0 and ENDOTINE Triple 3.0, which are designed for brow fixation, along with ENDOTINE Midface ST 4.5 for midface suspension. Other offerings include the ENDOTINE Ribbon and various surgical tools such as manual surgical drills and incisionless dissectors for precise application. Coapt's implants are utilized in procedures like forehead lifts, brow lifts, and midface and neck suspensions, catering to the needs of plastic surgeons in enhancing patient outcomes.
CardioMEMS
Series F in 2009
CardioMEMS is a medical device company specializing in wireless monitoring solutions for severe chronic cardiovascular conditions. Their proprietary technology involves miniature sensors implanted via minimally invasive procedures, transmitting vital data like cardiac output, blood pressure, and heart rate to enhance patient management, particularly for heart failure, hypertension, and aneurysms.
MedAptus
Venture Round in 2009
MedAptus, Inc. is a provider of clinical workforce and workflow solutions tailored for healthcare environments, including hospitals, health systems, and group practices. The company's offerings encompass a range of charge capture technologies designed to enhance the efficiency of healthcare providers. Key products include Pro Charge Capture, which assists physicians and administrative staff in managing billing and coding; Assign for Rounding Providers and Assign for Care Team Members, which optimize patient assignments; and MedAptus Collaborate, a secure communication tool for caregivers. Additional solutions include various editions addressing the specific needs of different healthcare settings, such as inpatient care, outpatient clinics, and academic practice plans. Founded in 1999 and based in Boston, Massachusetts, MedAptus aims to streamline clinical operations, improve patient management, and facilitate collaboration among care teams. The company was previously known as MedCompanion, Inc. and became a subsidiary of Volaris Group Inc. in 2020.
Histogenics
Series B in 2008
Histogenics Corporation, founded in 2000 and headquartered in Waltham, Massachusetts, is a regenerative medicine company specializing in the development and commercialization of therapeutic medical products for musculoskeletal conditions. The company's innovative platform integrates cell processing, scaffolding, tissue engineering, bioadhesives, and growth factors to address cartilage damage and improve joint function. Its primary investigational product, NeoCart, is a tissue implant designed to treat cartilage injuries in the knee, aiming to regenerate healthy cartilage and enhance overall joint performance. In 2019, Histogenics was acquired by Ocugen, Inc., marking a significant transition in its corporate structure.
Collegium Pharmaceutical
Series D in 2008
Collegium Pharmaceutical, Inc. is a specialty pharmaceutical company dedicated to developing and commercializing products aimed at addressing the challenges associated with pain management and the abuse of prescription drugs. The company utilizes its proprietary DETERx platform technology to create abuse-deterrent formulations that maintain the extended-release and safety profiles of medications, making them less susceptible to misuse through methods such as chewing or injecting. Collegium's primary products include Xtampza ER, an abuse-deterrent extended-release formulation of oxycodone, and Nucynta, which encompasses both extended-release and immediate-release formulations of tapentadol for managing severe pain. Founded in 2002 and headquartered in Stoughton, Massachusetts, Collegium focuses on delivering innovative solutions that enhance patient safety while effectively treating chronic pain conditions.
SensorLogic
Series C in 2008
SensorLogic is a provider of cloud-based, machine-to-machine (M2M) service delivery solutions, specializing in a platform-as-a-service (PaaS) model tailored for M2M applications. The company's offerings include a customizable service delivery platform that features open device and network management, business logic, and complex event processing capabilities. With its XpressIQ Service Suite, SensorLogic enables customers to access ready-to-use applications for GPS tracking, asset monitoring, and control, along with value-added network services. The platform is designed to facilitate the development and deployment of innovative M2M applications, capitalizing on the integration of connected devices within a nationwide GSM/GPRS network.
Arthrosurface
Series F in 2008
Arthrosurface, Inc. is an orthopedic medical device company based in Franklin, Massachusetts, specializing in minimally invasive joint resurfacing systems. Founded in 2002, the company designs and manufactures surface implant curvatures for various joints, including the knee, shoulder, wrist, hip, foot, ankle, and toe, aimed at treating orthopedic conditions stemming from trauma, injury, and arthritis. Arthrosurface's innovative devices are developed with an eye toward preserving native joint anatomy and maintaining normal biomechanics, thus allowing patients to experience improved range of motion and reduced pain. The company emphasizes a quick recovery and return to active lifestyles, enabling individuals to engage in activities such as CrossFit and Powerlifting. Operating through a network of sales representatives and distributors, Arthrosurface continues to make significant strides in joint preservation and replacement technology, contributing to the well-being of patients both in the United States and internationally. As of 2020, Arthrosurface operates as a subsidiary of Anika Therapeutics, Inc.
MedAptus
Venture Round in 2007
MedAptus, Inc. is a provider of clinical workforce and workflow solutions tailored for healthcare environments, including hospitals, health systems, and group practices. The company's offerings encompass a range of charge capture technologies designed to enhance the efficiency of healthcare providers. Key products include Pro Charge Capture, which assists physicians and administrative staff in managing billing and coding; Assign for Rounding Providers and Assign for Care Team Members, which optimize patient assignments; and MedAptus Collaborate, a secure communication tool for caregivers. Additional solutions include various editions addressing the specific needs of different healthcare settings, such as inpatient care, outpatient clinics, and academic practice plans. Founded in 1999 and based in Boston, Massachusetts, MedAptus aims to streamline clinical operations, improve patient management, and facilitate collaboration among care teams. The company was previously known as MedCompanion, Inc. and became a subsidiary of Volaris Group Inc. in 2020.
CardioMEMS
Series E in 2007
CardioMEMS is a medical device company specializing in wireless monitoring solutions for severe chronic cardiovascular conditions. Their proprietary technology involves miniature sensors implanted via minimally invasive procedures, transmitting vital data like cardiac output, blood pressure, and heart rate to enhance patient management, particularly for heart failure, hypertension, and aneurysms.
Infotrieve
Series C in 2007
Infotrieve, Inc. is an information management company that specializes in providing consulting and business service solutions for information centers within large and middle-market corporations. Founded in 1987 and headquartered in Wilton, Connecticut, Infotrieve offers a range of services including document delivery, library staffing, and information management. Its products include STM Library for collection management in the scientific, technical, and medical sectors, and Virtual Library 2.0, an automated document sourcing and delivery platform. Additionally, the company provides Ariel Interlibrary Loan Document Transmission Software, which facilitates document transmission via the Internet, and copyright compliance services. Infotrieve also delivers enterprise-level content sourcing and management solutions through its Content SCM service, along with tools for product and marketing managers such as reprints, eprints, and eDetailing. Its flagship Mobile Library service enhances content access and management on mobile platforms, further solidifying Infotrieve's position in the information management industry.
Arthrosurface
Series F in 2007
Arthrosurface, Inc. is an orthopedic medical device company based in Franklin, Massachusetts, specializing in minimally invasive joint resurfacing systems. Founded in 2002, the company designs and manufactures surface implant curvatures for various joints, including the knee, shoulder, wrist, hip, foot, ankle, and toe, aimed at treating orthopedic conditions stemming from trauma, injury, and arthritis. Arthrosurface's innovative devices are developed with an eye toward preserving native joint anatomy and maintaining normal biomechanics, thus allowing patients to experience improved range of motion and reduced pain. The company emphasizes a quick recovery and return to active lifestyles, enabling individuals to engage in activities such as CrossFit and Powerlifting. Operating through a network of sales representatives and distributors, Arthrosurface continues to make significant strides in joint preservation and replacement technology, contributing to the well-being of patients both in the United States and internationally. As of 2020, Arthrosurface operates as a subsidiary of Anika Therapeutics, Inc.
Odyssey Logistics & Technology
Series C in 2007
Odyssey Logistics & Technology Corporation is a global logistics solutions provider based in Danbury, Connecticut, specializing in managed logistics and transportation services. Founded in 2002, the company operates a freight network valued at over $3 billion and offers a wide range of services, including intermodal transportation, specialized trucking, international freight forwarding, and warehousing. Odyssey's offerings are designed to enhance supply chain performance through a proprietary technology platform and a network of logistics engineers. The company serves various industries, including chemicals, food, energy, and manufacturing, and is noted for its focus on safety, quality, and sustainability. Its Door-To-Done® approach addresses complex logistics needs while ensuring environmentally responsible operations. Additionally, Odyssey is recognized as a Responsible Care® partner by the American Chemistry Council and is involved in community support initiatives. The company's operations extend across North America, Europe, Asia, and the Far East.
Xconomy, Inc. is a media company based in Cambridge, Massachusetts, that delivers timely and insightful news focused on business, life sciences, and technology across various U.S. cities, including Boston, Seattle, and San Francisco. Founded in 2007, Xconomy serves a diverse audience of entrepreneurs, venture capitalists, angel investors, and business executives by providing detailed information on local personalities, companies, and technological trends that define the high-tech economy. The company operates a global network of localized news sites and engages users through events, conferences, and other initiatives aimed at fostering connections among innovators and leaders in the field. Additionally, Xconomy offers advertising opportunities, including banner ads and display ads, to support its mission of keeping stakeholders informed about the latest developments in the market.
SensorLogic
Series B in 2007
SensorLogic is a provider of cloud-based, machine-to-machine (M2M) service delivery solutions, specializing in a platform-as-a-service (PaaS) model tailored for M2M applications. The company's offerings include a customizable service delivery platform that features open device and network management, business logic, and complex event processing capabilities. With its XpressIQ Service Suite, SensorLogic enables customers to access ready-to-use applications for GPS tracking, asset monitoring, and control, along with value-added network services. The platform is designed to facilitate the development and deployment of innovative M2M applications, capitalizing on the integration of connected devices within a nationwide GSM/GPRS network.
Coapt Systems
Series E in 2007
Coapt Systems, Inc. specializes in the design, development, and manufacture of bio-absorbable implants used in soft tissue fixation during facial cosmetic surgery. The company offers a range of products, including the ENDOTINE Forehead 3.0 and ENDOTINE Triple 3.0, which are designed for brow fixation, along with ENDOTINE Midface ST 4.5 for midface suspension. Other offerings include the ENDOTINE Ribbon and various surgical tools such as manual surgical drills and incisionless dissectors for precise application. Coapt's implants are utilized in procedures like forehead lifts, brow lifts, and midface and neck suspensions, catering to the needs of plastic surgeons in enhancing patient outcomes.
CardioMEMS
Series D in 2006
CardioMEMS is a medical device company specializing in wireless monitoring solutions for severe chronic cardiovascular conditions. Their proprietary technology involves miniature sensors implanted via minimally invasive procedures, transmitting vital data like cardiac output, blood pressure, and heart rate to enhance patient management, particularly for heart failure, hypertension, and aneurysms.
Collegium Pharmaceutical
Series C in 2006
Collegium Pharmaceutical, Inc. is a specialty pharmaceutical company dedicated to developing and commercializing products aimed at addressing the challenges associated with pain management and the abuse of prescription drugs. The company utilizes its proprietary DETERx platform technology to create abuse-deterrent formulations that maintain the extended-release and safety profiles of medications, making them less susceptible to misuse through methods such as chewing or injecting. Collegium's primary products include Xtampza ER, an abuse-deterrent extended-release formulation of oxycodone, and Nucynta, which encompasses both extended-release and immediate-release formulations of tapentadol for managing severe pain. Founded in 2002 and headquartered in Stoughton, Massachusetts, Collegium focuses on delivering innovative solutions that enhance patient safety while effectively treating chronic pain conditions.
Nexidia Inc. is a technology company specializing in dialogue and audio analysis products designed to optimize audio and video media. Founded in 2000 and headquartered in Atlanta, Georgia, Nexidia offers a range of solutions including Nexidia Interaction Analytics for analyzing contact center interactions, Nexidia Capture for call recording, and Nexidia Dialogue Search which allows users to search audio content by keywords. The company provides various tools for automating closed captioning and ensuring compliance with video descriptions, as well as Audio Discovery OnDemand for organizing sound recordings. Nexidia also offers consulting, training, support services, and software development kits for unstructured audio search. Its clientele spans multiple industries, including communications, healthcare, financial services, and entertainment, enabling organizations to extract value from unstructured audio and video content. Formerly known as Fast-Talk Communications, Nexidia became a subsidiary of NICE Systems Ltd. in 2016.
Athenix is a prominent company in the field of agricultural and industrial biotechnology, specializing in the development of innovative products, technologies, and processes for agricultural and chemical applications. The company has established a robust infrastructure dedicated to the discovery of new genes, which are then developed into practical solutions that address the needs of its customers. Athenix focuses on creating plants, microbes, and enzymes that provide resistance to insects and nematodes, as well as herbicide tolerance. Additionally, the company is involved in the discovery of genes and proteins that are applicable in the chemical and animal feed industries.
GlycoFi is a biotech company focused on developing biotherapeutics utilizing glycan optimization technology. Founded in 2000 and based in Lebanon, New Hampshire, the firm specializes in a proprietary protein manufacturing process that employs engineered yeast strains to achieve precise human glycosylation. This innovative approach enables the creation of therapeutic proteins, which are essential for drug development. GlycoFi aims to build its own pipeline of products while also collaborating with other pharmaceutical companies to enhance their drug offerings. In 2006, GlycoFi became a subsidiary of Merck & Co. Inc., further expanding its capabilities in the biotherapeutics field.
Nexidia Inc. is a technology company specializing in dialogue and audio analysis products designed to optimize audio and video media. Founded in 2000 and headquartered in Atlanta, Georgia, Nexidia offers a range of solutions including Nexidia Interaction Analytics for analyzing contact center interactions, Nexidia Capture for call recording, and Nexidia Dialogue Search which allows users to search audio content by keywords. The company provides various tools for automating closed captioning and ensuring compliance with video descriptions, as well as Audio Discovery OnDemand for organizing sound recordings. Nexidia also offers consulting, training, support services, and software development kits for unstructured audio search. Its clientele spans multiple industries, including communications, healthcare, financial services, and entertainment, enabling organizations to extract value from unstructured audio and video content. Formerly known as Fast-Talk Communications, Nexidia became a subsidiary of NICE Systems Ltd. in 2016.
Novalar Pharmaceuticals
Series C in 2005
Novalar Pharmaceuticals, Inc., a pharmaceutical company, develops oral pharmaceutical products. It focuses on dental products. The company’s OraVerse product (phentolamine mesylate) reverses the effects of local anesthetic with a vasoconstrictor and accelerates the return of normal sensation and function. Novalar Pharmaceuticals, Inc. was founded in 2000 and is based in San Diego, California. As of March 22, 2011, Novalar Pharmaceuticals, Inc. operates as a subsidiary of Septodont Limited.
Netifice Communications
Venture Round in 2005
Netifice Communications is redefining how Managed Service Providers deliver secure IP data and voice communication services.
Arthrosurface
Venture Round in 2005
Arthrosurface, Inc. is an orthopedic medical device company based in Franklin, Massachusetts, specializing in minimally invasive joint resurfacing systems. Founded in 2002, the company designs and manufactures surface implant curvatures for various joints, including the knee, shoulder, wrist, hip, foot, ankle, and toe, aimed at treating orthopedic conditions stemming from trauma, injury, and arthritis. Arthrosurface's innovative devices are developed with an eye toward preserving native joint anatomy and maintaining normal biomechanics, thus allowing patients to experience improved range of motion and reduced pain. The company emphasizes a quick recovery and return to active lifestyles, enabling individuals to engage in activities such as CrossFit and Powerlifting. Operating through a network of sales representatives and distributors, Arthrosurface continues to make significant strides in joint preservation and replacement technology, contributing to the well-being of patients both in the United States and internationally. As of 2020, Arthrosurface operates as a subsidiary of Anika Therapeutics, Inc.
Odyssey Logistics & Technology
Series B in 2005
Odyssey Logistics & Technology Corporation is a global logistics solutions provider based in Danbury, Connecticut, specializing in managed logistics and transportation services. Founded in 2002, the company operates a freight network valued at over $3 billion and offers a wide range of services, including intermodal transportation, specialized trucking, international freight forwarding, and warehousing. Odyssey's offerings are designed to enhance supply chain performance through a proprietary technology platform and a network of logistics engineers. The company serves various industries, including chemicals, food, energy, and manufacturing, and is noted for its focus on safety, quality, and sustainability. Its Door-To-Done® approach addresses complex logistics needs while ensuring environmentally responsible operations. Additionally, Odyssey is recognized as a Responsible Care® partner by the American Chemistry Council and is involved in community support initiatives. The company's operations extend across North America, Europe, Asia, and the Far East.
Fast Channel Network
Venture Round in 2005
Fast Channel Network is a technology-driven company that provides innovative solutions for the advertising and B2B sectors. It offers a comprehensive suite of tools through its FastChannel Intelligence and Control platform, which includes features for competitor tracking, creative resource management, broadcast verification, and digital asset management. The company also operates an extensive online media distribution network, connecting over 5,000 advertisers and agencies to more than 21,000 online broadcast and publishing destinations. Additionally, Fast Channel focuses on digitizing B2B sales channels for medium and large enterprises, importers, and distributors, helping them enhance their online sales through a specialized e-commerce platform and integrated marketplace solutions.
SensorLogic
Series A in 2004
SensorLogic is a provider of cloud-based, machine-to-machine (M2M) service delivery solutions, specializing in a platform-as-a-service (PaaS) model tailored for M2M applications. The company's offerings include a customizable service delivery platform that features open device and network management, business logic, and complex event processing capabilities. With its XpressIQ Service Suite, SensorLogic enables customers to access ready-to-use applications for GPS tracking, asset monitoring, and control, along with value-added network services. The platform is designed to facilitate the development and deployment of innovative M2M applications, capitalizing on the integration of connected devices within a nationwide GSM/GPRS network.
Rejuvenon
Series B in 2004
Rejuvenon a biopharmaceutical company committed developing and commercializing promising compounds for treatment of oncologic diseases.
Tropos Networks
Series D in 2004
Tropos Networks is a provider of technology and products designed to create reliable and scalable wireless broadband networks, particularly for metro-scale applications. The company specializes in building extensive Wi-Fi networks that enable network operators, service providers, and government entities to deliver widespread wireless data coverage. Tropos' solutions eliminate the need for wired connections typically required by traditional Wi-Fi hotspots, resulting in larger coverage areas and reduced installation and operational costs. Their offerings include the MetroMesh OS, which features advanced capabilities such as predictive wireless routing, adaptive mesh connectivity, and self-organizing mesh routing intelligence. This technology is particularly suited for smart grid applications and other outdoor industrial uses, facilitating efficient and secure wireless communication in diverse environments.
Continuum Photonics
Series C in 2004
Continuum Photonics specializes in the development of optical layer connectivity products designed for managing and switching fiber-based optical networks. The company focuses on providing manufacturers of optical networking equipment with innovative subsystems that facilitate higher bandwidth capabilities and revenue-generating services at reduced costs. Among its key offerings are single-mode and multi-mode optical matrix switches, carrier optical monitor switches, and latching switches. Continuum Photonics is currently advancing a novel photonic switch aimed at addressing various challenges related to the delivery and management of optically-transported bandwidth, highlighting its commitment to enhancing operational efficiency and economic viability in the optical networking industry.
CombinatoRx
Series C in 2004
CombinatoRx is a biotech company that develops medicines from synergistic combinations of approved drugs. The company has pushed into Phase 2 clinical trials a portfolio of drug candidates aimed at cancer and multiple immuno-inflammatory diseases. CombinatoRx Service Business was acquired by Horizon Discovery Group.
Zalicus Inc. is a biopharmaceutical company based in Cambridge, Massachusetts, focused on the development of drug candidates aimed at treating pain and inflammation. The company specializes in ion-channel modulation, using its expertise to discover therapeutics that may effectively block ion channels in neuronal cells responsible for pain signal transmission. Zalicus has invested significantly in its drug discovery technology, as well as the research and development of its product candidates, which includes conducting preclinical and clinical trials. The company has also sought intellectual property protection for its innovative technologies. Its notable achievement includes the approval of Exalgo, an extended-release formulation of hydromorphone for managing moderate to severe pain in opioid-tolerant patients, granted by the United States Food and Drug Administration in 2010. Additionally, Zalicus merged with Neuromed Pharmaceuticals in 2009, further expanding its capabilities in pain management therapies.
Athenix is a prominent company in the field of agricultural and industrial biotechnology, specializing in the development of innovative products, technologies, and processes for agricultural and chemical applications. The company has established a robust infrastructure dedicated to the discovery of new genes, which are then developed into practical solutions that address the needs of its customers. Athenix focuses on creating plants, microbes, and enzymes that provide resistance to insects and nematodes, as well as herbicide tolerance. Additionally, the company is involved in the discovery of genes and proteins that are applicable in the chemical and animal feed industries.
Infotrieve
Series B in 2004
Infotrieve, Inc. is an information management company that specializes in providing consulting and business service solutions for information centers within large and middle-market corporations. Founded in 1987 and headquartered in Wilton, Connecticut, Infotrieve offers a range of services including document delivery, library staffing, and information management. Its products include STM Library for collection management in the scientific, technical, and medical sectors, and Virtual Library 2.0, an automated document sourcing and delivery platform. Additionally, the company provides Ariel Interlibrary Loan Document Transmission Software, which facilitates document transmission via the Internet, and copyright compliance services. Infotrieve also delivers enterprise-level content sourcing and management solutions through its Content SCM service, along with tools for product and marketing managers such as reprints, eprints, and eDetailing. Its flagship Mobile Library service enhances content access and management on mobile platforms, further solidifying Infotrieve's position in the information management industry.
Galt Associates
Venture Round in 2004
Galt is an international leader in helping clients manage risk through information. Galt's evidence-based solutions integrate the recognized expertise of its medical and scientific personnel with innovative technologies to ensure timely answers to clients' critical questions. This integrated approach allows Galt to deliver medical risk management and communication strategies that address the benefits and risks associated with the full range of medical therapies and interventions. Galt supports more than 70 pharmaceutical, medical device and biotechnology companies, as well as contract research organizations (CRO) and research institutions located throughout the U.S. and Europe
Novalar Pharmaceuticals
Series B in 2003
Novalar Pharmaceuticals, Inc., a pharmaceutical company, develops oral pharmaceutical products. It focuses on dental products. The company’s OraVerse product (phentolamine mesylate) reverses the effects of local anesthetic with a vasoconstrictor and accelerates the return of normal sensation and function. Novalar Pharmaceuticals, Inc. was founded in 2000 and is based in San Diego, California. As of March 22, 2011, Novalar Pharmaceuticals, Inc. operates as a subsidiary of Septodont Limited.
MedAptus
Venture Round in 2003
MedAptus, Inc. is a provider of clinical workforce and workflow solutions tailored for healthcare environments, including hospitals, health systems, and group practices. The company's offerings encompass a range of charge capture technologies designed to enhance the efficiency of healthcare providers. Key products include Pro Charge Capture, which assists physicians and administrative staff in managing billing and coding; Assign for Rounding Providers and Assign for Care Team Members, which optimize patient assignments; and MedAptus Collaborate, a secure communication tool for caregivers. Additional solutions include various editions addressing the specific needs of different healthcare settings, such as inpatient care, outpatient clinics, and academic practice plans. Founded in 1999 and based in Boston, Massachusetts, MedAptus aims to streamline clinical operations, improve patient management, and facilitate collaboration among care teams. The company was previously known as MedCompanion, Inc. and became a subsidiary of Volaris Group Inc. in 2020.
Nexidia Inc. is a technology company specializing in dialogue and audio analysis products designed to optimize audio and video media. Founded in 2000 and headquartered in Atlanta, Georgia, Nexidia offers a range of solutions including Nexidia Interaction Analytics for analyzing contact center interactions, Nexidia Capture for call recording, and Nexidia Dialogue Search which allows users to search audio content by keywords. The company provides various tools for automating closed captioning and ensuring compliance with video descriptions, as well as Audio Discovery OnDemand for organizing sound recordings. Nexidia also offers consulting, training, support services, and software development kits for unstructured audio search. Its clientele spans multiple industries, including communications, healthcare, financial services, and entertainment, enabling organizations to extract value from unstructured audio and video content. Formerly known as Fast-Talk Communications, Nexidia became a subsidiary of NICE Systems Ltd. in 2016.
CardioMEMS
Series B in 2003
CardioMEMS is a medical device company specializing in wireless monitoring solutions for severe chronic cardiovascular conditions. Their proprietary technology involves miniature sensors implanted via minimally invasive procedures, transmitting vital data like cardiac output, blood pressure, and heart rate to enhance patient management, particularly for heart failure, hypertension, and aneurysms.
Protein Forest
Series A in 2003
Protein Forest, Inc. is a biotechnology company based in Lexington, Massachusetts, specializing in the development, manufacture, and marketing of instruments, consumables, and software products designed for protein separation and bioanalysis. Founded in 2002, the company offers innovative solutions such as the digital ProteomeChip (dPC), which utilizes isoelectric focusing to fractionate and concentrate proteins or peptides for mass spectrometry analysis and western blotting. Their product line includes the dPC fractionator, which operates under controlled conditions for sample processing, the dPC fractionator workflow that integrates seamlessly with existing mass spectroscopy workflows, and the dPC PlugHarvestor, allowing users to efficiently select and group pH gel plugs. Protein Forest serves a diverse clientele in the life sciences, drug discovery, pharmaceutical, biotech, and diagnostic industries, providing essential tools for scientific research and development.
Collegium Pharmaceutical
Series A in 2003
Collegium Pharmaceutical, Inc. is a specialty pharmaceutical company dedicated to developing and commercializing products aimed at addressing the challenges associated with pain management and the abuse of prescription drugs. The company utilizes its proprietary DETERx platform technology to create abuse-deterrent formulations that maintain the extended-release and safety profiles of medications, making them less susceptible to misuse through methods such as chewing or injecting. Collegium's primary products include Xtampza ER, an abuse-deterrent extended-release formulation of oxycodone, and Nucynta, which encompasses both extended-release and immediate-release formulations of tapentadol for managing severe pain. Founded in 2002 and headquartered in Stoughton, Massachusetts, Collegium focuses on delivering innovative solutions that enhance patient safety while effectively treating chronic pain conditions.
PHT is a leading provider of electronic patient reported outcome (ePRO) solutions utilized in clinical trials globally. The company specializes in web-based direct data capture and management technologies that enhance data quality, facilitating more accurate and comprehensive information collection for biopharmaceutical and medical device companies. PHT's LogPad and StudyPad Systems streamline trial processes, while the robust StudyWorks online portal offers study sponsors, monitors, and sites real-time access to critical data. This enables faster decision-making and ultimately contributes to the success of clinical trials, making PHT an essential partner in the pharmaceutical and clinical research sectors.
Arthrosurface
Series B in 2003
Arthrosurface, Inc. is an orthopedic medical device company based in Franklin, Massachusetts, specializing in minimally invasive joint resurfacing systems. Founded in 2002, the company designs and manufactures surface implant curvatures for various joints, including the knee, shoulder, wrist, hip, foot, ankle, and toe, aimed at treating orthopedic conditions stemming from trauma, injury, and arthritis. Arthrosurface's innovative devices are developed with an eye toward preserving native joint anatomy and maintaining normal biomechanics, thus allowing patients to experience improved range of motion and reduced pain. The company emphasizes a quick recovery and return to active lifestyles, enabling individuals to engage in activities such as CrossFit and Powerlifting. Operating through a network of sales representatives and distributors, Arthrosurface continues to make significant strides in joint preservation and replacement technology, contributing to the well-being of patients both in the United States and internationally. As of 2020, Arthrosurface operates as a subsidiary of Anika Therapeutics, Inc.
Odyssey Logistics & Technology
Series A in 2003
Odyssey Logistics & Technology Corporation is a global logistics solutions provider based in Danbury, Connecticut, specializing in managed logistics and transportation services. Founded in 2002, the company operates a freight network valued at over $3 billion and offers a wide range of services, including intermodal transportation, specialized trucking, international freight forwarding, and warehousing. Odyssey's offerings are designed to enhance supply chain performance through a proprietary technology platform and a network of logistics engineers. The company serves various industries, including chemicals, food, energy, and manufacturing, and is noted for its focus on safety, quality, and sustainability. Its Door-To-Done® approach addresses complex logistics needs while ensuring environmentally responsible operations. Additionally, Odyssey is recognized as a Responsible Care® partner by the American Chemistry Council and is involved in community support initiatives. The company's operations extend across North America, Europe, Asia, and the Far East.
Entigo
Venture Round in 2003
Entigo is a company that develops enterprise warranty chain management solutions, aimed at streamlining warranty processing for businesses. Its flagship product, Entigo Warranty, facilitates the administration of warranty claims and registrations, while Entigo Catalyst assists in evaluating and enhancing current warranty processes. The company offers a range of services, including project management, implementation consulting, and systems integration, which help automate claims processing, reduce errors, and improve overall efficiency. Entigo's solutions also incorporate analytics and reporting capabilities, enabling clients to make data-driven decisions that enhance product quality and minimize warranty costs. Serving a diverse clientele that includes Fortune 500 manufacturers in sectors such as automotive, aerospace, and industrial equipment, Entigo is committed to simplifying warranty processes and fostering collaboration among warranty chain partners. Founded in 1995, the company is headquartered in Exton, Pennsylvania.
Tropos Networks
Series C in 2003
Tropos Networks is a provider of technology and products designed to create reliable and scalable wireless broadband networks, particularly for metro-scale applications. The company specializes in building extensive Wi-Fi networks that enable network operators, service providers, and government entities to deliver widespread wireless data coverage. Tropos' solutions eliminate the need for wired connections typically required by traditional Wi-Fi hotspots, resulting in larger coverage areas and reduced installation and operational costs. Their offerings include the MetroMesh OS, which features advanced capabilities such as predictive wireless routing, adaptive mesh connectivity, and self-organizing mesh routing intelligence. This technology is particularly suited for smart grid applications and other outdoor industrial uses, facilitating efficient and secure wireless communication in diverse environments.
NuVox Communications
Private Equity Round in 2002
NuVox Communications is a provider of broadband services that focuses on delivering voice and data network communications to businesses across the United States. The company offers a range of services including conference calling, data security and backup, internet access, voicemail, and web hosting. With a commitment to supporting business communication needs, NuVox aims to enhance operational efficiency and connectivity for its clients through reliable managed services.
Novalar Pharmaceuticals
Series A in 2002
Novalar Pharmaceuticals, Inc., a pharmaceutical company, develops oral pharmaceutical products. It focuses on dental products. The company’s OraVerse product (phentolamine mesylate) reverses the effects of local anesthetic with a vasoconstrictor and accelerates the return of normal sensation and function. Novalar Pharmaceuticals, Inc. was founded in 2000 and is based in San Diego, California. As of March 22, 2011, Novalar Pharmaceuticals, Inc. operates as a subsidiary of Septodont Limited.
Nexidia Inc. is a technology company specializing in dialogue and audio analysis products designed to optimize audio and video media. Founded in 2000 and headquartered in Atlanta, Georgia, Nexidia offers a range of solutions including Nexidia Interaction Analytics for analyzing contact center interactions, Nexidia Capture for call recording, and Nexidia Dialogue Search which allows users to search audio content by keywords. The company provides various tools for automating closed captioning and ensuring compliance with video descriptions, as well as Audio Discovery OnDemand for organizing sound recordings. Nexidia also offers consulting, training, support services, and software development kits for unstructured audio search. Its clientele spans multiple industries, including communications, healthcare, financial services, and entertainment, enabling organizations to extract value from unstructured audio and video content. Formerly known as Fast-Talk Communications, Nexidia became a subsidiary of NICE Systems Ltd. in 2016.
WebCT
Venture Round in 2002
WebCT, Inc. is a leading provider of e-learning solutions specifically designed for higher education institutions, colleges, and universities. Founded with the vision of creating a flexible and integrated educational environment, WebCT aims to enhance the academic experience by utilizing advanced technology to promote inquiry, collaboration, and discourse among students. The company offers a comprehensive suite of learning management solutions that integrate various pedagogical tools with existing campus infrastructures. In addition to its core products, WebCT provides a range of services, including technical support, professional development, and hosting options, all tailored to simplify the learning process for institutions. Through its innovative offerings, WebCT is dedicated to transforming the educational experience for students worldwide.
TechSmart.com
Venture Round in 2002
TechSmart.com (the "Company"), formed in April 1997 under the name Linx Technologies, offers original equipment manufacturers, lessors, retailers, e-tailers and large corporations a web-based asset recovery solution ("Assets into Money") to effectively manage and resell their returned, refreshed, off-lease and overstock office technology assets ("recovered assets"). These businesses, which They call SmartPartners, send their technology assets to TechSmart.com's processing facilities where the assets are audited, tested, cleaned, packaged and remarketed through the Company's web site. Historically, businesses with recovered assets operated an inefficient in-house program in conjunction with a multi-tiered chain of "mom and pop" refurbishers, brokers, resellers and service providers. Because recovered asset management is not a core competency of these asset owners, they incurred excessive processing costs and achieved sales far below fair market value.
PhotonEx is a prominent event in the UK, focusing on photonics and light technologies. It serves as a platform to showcase innovations and advancements in this field, bringing together industry experts, researchers, and businesses to discuss and explore the latest developments. In addition to organizing this event, PhotonEx is involved in the development of smart photonic systems aimed at enhancing public telecommunications networks. By integrating cutting-edge photonic technologies, the company aims to improve the efficiency and performance of telecommunications infrastructure. Through its initiatives, PhotonEx plays a crucial role in promoting the growth and application of photonics in various sectors.
Athenix is a prominent company in the field of agricultural and industrial biotechnology, specializing in the development of innovative products, technologies, and processes for agricultural and chemical applications. The company has established a robust infrastructure dedicated to the discovery of new genes, which are then developed into practical solutions that address the needs of its customers. Athenix focuses on creating plants, microbes, and enzymes that provide resistance to insects and nematodes, as well as herbicide tolerance. Additionally, the company is involved in the discovery of genes and proteins that are applicable in the chemical and animal feed industries.
Verio
Venture Round in 2001
Verio Inc. is a prominent provider of online business solutions, specializing in shared website hosting, domain name registration, and virtual private server (VPS) hosting. Its offerings extend to website design, SSL certification, Microsoft Exchange services, and various marketing services such as search engine optimization and email marketing. Catering primarily to individuals and small to medium-sized businesses, Verio also provides support services through multiple channels including phone, email, and online chat. Originally established as WorldNet Access, Inc. and renamed in 1997, the company is headquartered in Orem, Utah, with data centers located in Boston, Massachusetts. As a subsidiary of NTT Communications, Verio leverages a global IP network that enables it to deliver reliable and scalable solutions to clients in over 200 countries.
iParty
Venture Round in 2001
iParty is a retailer specializing in party supplies and related goods, operating both physical stores and an online platform primarily in New England and Florida. The company offers a diverse range of products, including paper party goods, costumes, greeting cards, and various accessories such as wigs, hats, and balloons. iParty aims to cater to a wide array of celebration needs, making it a go-to destination for consumers seeking to enhance their festive occasions.